Peer-influenced content. Sources you trust. No registration required. This is HCN.
Oncology News Central (ONC)
The FDA has withdrawn approval for infigratinib in advanced cholangiocarcinoma following Helsinn Healthcare SA’s request, citing recruitment difficulties for a confirmatory trial.
Oncology, Medical June 17th 2024
The New England Journal of Medicine
Hypomagnesemia, prevalent in patients with type 2 diabetes and those in intensive care, is often underdiagnosed due to nonspecific symptoms and lack of routine serum magnesium measurements.
Endocrinology, Diabetes, Metabolism June 11th 2024
MDLinx
Sexsomnia, a sleep disorder involving unconscious sexual behaviors, presents significant diagnostic and treatment challenges. Comprehensive evaluations and behavioral interventions are key to managing this condition.
All Specialties May 22nd 2024
Dr. Feinstein’s journey in caring for children with epidermolysis bullosa reveals the necessity of proper goodbyes to cope with the emotional challenges of terminal patient care.
All Specialties May 20th 2024
In a challenging case of polyarteritis nodosa, angiography and histopathology provided crucial diagnostic insights, leading to successful management through tailored immunosuppressive therapy.
Emergency Medicine May 14th 2024
Cleveland Clinic Journal of Medicine
In a complex case of pseudomyxoma peritonei, detailed imaging and cytological analysis were crucial in identifying a rare pancreaticobiliary origin, highlighting the importance of a thorough diagnostic approach in unusual presentations of ascites.
Gastroenterology May 13th 2024